Superinvestor Tracker
← All Investors

BRIDGEBIO PHARMA INC

BBIO 2.5 03-15-27

Holders

2

Combined Value

$44M

Combined Shares

24,944,000

Investor Activity

$0.81$1.26$1.71$2.17Q2'24Q3'24Q4'24Q1'25Q2'25Q3'25Q4'25Q1'26▲2▲1 ▼1▲1 ▼1▲2 ▼1▲3 ▼1▼2▲2 ▼1▲1 ▼1
BUYSELLImplied priceClick a quarter to see who traded

Held By

InvestorValue% of PortfolioAvg Buy PriceGainLast ActivityAs of
Israel Englander - Millennium Management$44M0.02%~$1.57—Bought Q1 2026Q1 2026
Mario Gabelli - GAMCO Investors$542K0.01%~$1.25—Bought Q2 2025Q1 2026

Recent Activity

QuarterInvestorActionEst. ValueEst. Price
Q1 2026Ken Griffin - Citadel AdvisorsSOLD OUT−$83M~$1.89
Q1 2026Israel Englander - Millennium ManagementBUY+$6M~$1.80
Q4 2025Ken Griffin - Citadel AdvisorsBUY+$29M~$1.89
Q4 2025Israel Englander - Millennium ManagementBUY+$20M~$1.89
Q4 2025Howard Marks - Oaktree CapitalSOLD OUT−$2M~$1.41
Q3 2025Ken Griffin - Citadel AdvisorsSELL−$7M~$1.40
Q3 2025Howard Marks - Oaktree CapitalSELL−$351K~$1.41
Q2 2025Ken Griffin - Citadel AdvisorsNEW BUY+$42M~$1.25
Q2 2025Steve Cohen - Point72SOLD OUT−$31M~$1.14
Q2 2025Howard Marks - Oaktree CapitalBUY+$1M~$1.25
Q2 2025Mario Gabelli - GAMCO InvestorsNEW BUY+$375K~$1.25
Q1 2025Steve Cohen - Point72SELL−$11M~$1.14
Q1 2025Israel Englander - Millennium ManagementNEW BUY+$11M~$1.14
Q1 2025Howard Marks - Oaktree CapitalNEW BUY+$1M~$1.15
Q4 2024Steve Cohen - Point72BUY+$5M~$1.05
Q4 2024Howard Marks - Oaktree CapitalSOLD OUT−$1M~$1.03
Q3 2024Steve Cohen - Point72BUY+$11M~$1.03
Q3 2024Howard Marks - Oaktree CapitalSELL−$2M~$1.03
Q2 2024Steve Cohen - Point72NEW BUY+$21M~$1.01
Q2 2024Howard Marks - Oaktree CapitalNEW BUY+$3M~$1.02

Ownership History

PeriodHoldersTotal SharesΔ SharesTotal ValueImplied Price
Q1 2026224,944,000−62.1%$44M$1.80
Q4 2025365,805,000+59.9%$124M$1.89
Q3 2025441,155,000−11.3%$57M$1.40
Q2 2025446,405,000+19.8%$58M$1.25
Q1 2025338,750,000+3.3%$44M$1.14
Q4 2024137,500,000+11.1%$39M$1.05
Q3 2024233,746,000+36.7%$34M$1.03
Q2 2024224,691,000—$24M$1.01